Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samson W Fine

Showing results (131-140 of 175) with videos related to

Pageof 18
Sort By:
Urologic Oncology|February 15, 2021
Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancerGregory T Chesnut, Amy L Tin, Arjun Sivaraman, et al.
The Journal of Pathology|May 7, 2011
Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinomaHikmat A Al-Ahmadie, Gopa Iyer, Manickam Janakiraman, et al.
The American Journal of Surgical Pathology|May 2, 2015
Diagnosis of Gleason pattern 5 prostate adenocarcinoma on core needle biopsy: an interobserver reproducibility study among urologic pathologistsRajal B Shah, Jianbo Li, Liang Cheng, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 14, 2019
Extensive disease among potential candidates for hemi-ablative focal therapy for prostate cancerToshikazu Takeda, Amy L Tin, Renato B Corradi, et al.
European Urology|July 14, 2015
A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason ScoreJonathan I Epstein, Michael J Zelefsky, Daniel D Sjoberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Germline BRCA mutations denote a clinicopathologic subset of prostate cancerDavid J Gallagher, Mia M Gaudet, Prodipto Pal, et al.
The Journal of Urology|June 9, 2025
Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening: ErratumJohn T Wei, Daniel Barocas, Sigrid Carlsson, et al.
The Journal of Urology|April 25, 2023
Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate BiopsyJohn T Wei, Daniel Barocas, Sigrid Carlsson, et al.
Journal of Cancer|March 7, 2017
Immunohistochemical and molecular characterizations in urothelial carcinoma of bladder in patients less than 45 yearsVeronika Weyerer, Roland Schneckenpointner, Thomas Filbeck, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 14, 2019
Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 casesLiwei Jia, Maria I Carlo, Hina Khan, et al.
Pageof 18

Showing results (131-140 of 175) with videos related to

Sort By:
Pageof 18
Urologic Oncology|February 15, 2021
Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancerGregory T Chesnut, Amy L Tin, Arjun Sivaraman, et al.
The Journal of Pathology|May 7, 2011
Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinomaHikmat A Al-Ahmadie, Gopa Iyer, Manickam Janakiraman, et al.
The American Journal of Surgical Pathology|May 2, 2015
Diagnosis of Gleason pattern 5 prostate adenocarcinoma on core needle biopsy: an interobserver reproducibility study among urologic pathologistsRajal B Shah, Jianbo Li, Liang Cheng, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 14, 2019
Extensive disease among potential candidates for hemi-ablative focal therapy for prostate cancerToshikazu Takeda, Amy L Tin, Renato B Corradi, et al.
European Urology|July 14, 2015
A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason ScoreJonathan I Epstein, Michael J Zelefsky, Daniel D Sjoberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Germline BRCA mutations denote a clinicopathologic subset of prostate cancerDavid J Gallagher, Mia M Gaudet, Prodipto Pal, et al.
The Journal of Urology|June 9, 2025
Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening: ErratumJohn T Wei, Daniel Barocas, Sigrid Carlsson, et al.
The Journal of Urology|April 25, 2023
Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate BiopsyJohn T Wei, Daniel Barocas, Sigrid Carlsson, et al.
Journal of Cancer|March 7, 2017
Immunohistochemical and molecular characterizations in urothelial carcinoma of bladder in patients less than 45 yearsVeronika Weyerer, Roland Schneckenpointner, Thomas Filbeck, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 14, 2019
Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 casesLiwei Jia, Maria I Carlo, Hina Khan, et al.
Pageof 18